Skip to content

Custom Provisionalisation

The Esthetic Outcome of Custom-Designed Profisionalisations of Immediate Implants in the Esthetic Zone: a Randomized, Controlled, Clinical Trial.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07731854
Acronym
Azento
Enrollment
36
Registered
2026-07-28
Start date
2022-05-29
Completion date
2026-07-15
Last updated
2026-07-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tooth Loss and Rehabillitation

Keywords

guided implant surgery, immediate implant treatment, esthetic outcome, provisionalisation

Brief summary

Fully digital immediate implant treatment by means of fully guided implant placement and custom designed provisionalisation with a individual designed abutment and temporary PMMA crown leads to better esthetic outcomes than free handed with regular provisionalisation on a temporary cylinder.

Detailed description

Since many years dental implants serve as long-term predictable anchors for fixed and removable prostheses in fully and partially edentulous patients. A dental implant is a screw that is inserted into the jawbone to provide fixed support for a single crown, fixed partial/full denture or an overdenture. After local anaesthesia, the implant is inserted into a cavity that has been drilled into the jaw. New bone is allowed to grow around the implant for up to 3 till 6 months before a prosthetic device is attached. Via a connecting element - 'abutment' - the crown, bridge or denture is attached to the dental implant. The abutment can be placed immediately after implant placement - 'one-stage surgery' - or during a second surgery - 'two-stage surgery'. In certain cases this abutment can already contain a provisional crown (a tooth). Immediate implant placement and provisionalisation offers great benefits for the patient: one intervention, immediate tooth replacement, minimally invasiveness to name just a couple. However, in recent years, there has been a debate in the scientific community on the long term esthetic outcome. This is important as this concept is predominantly used in high esthetic regions. Scientific evidence is frequently contradictory and confusing. Digitalisation has found its way into implant dentistry. The combination of CBCT images and IO-scan images give the clinician and/or company the opportunity to plan the surgery in advance (even when the natural tooth is still in place). This might lead to 'guided' implant surgery (where the position of the implant is defined through a surgical guide) but also to custom-designed provisionalisation.

Interventions

immediate implant placement with digital workflow

PROCEDUREFree handed implant placement

immediate implant placement conventional workflow

PROCEDUREindividualised abutment + digital prepared provisional crown

immediate loading with digital workflow

PROCEDUREProvisional Cylinder + conventional provisional crown

immediate loading with conventional workflow

Sponsors

Universitaire Ziekenhuizen KU Leuven
Lead SponsorOTHER
University Hospital, Ghent
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
25 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures 2. Males or females ASA I or II, between 25 to 80 years of age 3. One tooth in the high esthetic region planned for extraction. 4. Patient in good general health as documented by self-assessment. 5. Patients must be committed to the study and must be willing to sign the informed consent.

Exclusion criteria

1. Any disorder, which in the Investigator's opinion might jeopardise the participant's safety or compliance with the protocol 2. Any prior or concomitant treatment(s) that might jeopardise the participant's safety or that would compromise the integrity of the Trial 3. Participation in an interventional Trial with an investigational medicinal product (IMP) or device 4. Any systemic medical condition that could interfere with the surgical procedure or planned treatment. 5. Immunosuppression, Diabetes, Anticoagulation or Antiaggregatory medication. 6. Current pregnancy or breast feeding/ lactating at the time of recruitment. 7. Radiotherapy or Chemotherapy in head and neck area. 8. Intravenous and oral bisphosphonate therapy. 9. Smokers 10. Unwillingness to return for the follow-up examination. 11. Conditions or circumstances, in the opinion of the investigator, which could represent a general contra-indication for surgical procedure or would prevent completion of study participation or interfere with analysis of study results, such as history of non-compliance, or unrealistic expectations. 12. Presence of osseous pathologies, that may interfere with normal wound healing. 13. Presence of oral lesions (such as ulceration, malignancy). 14. Local inflammation, including untreated periodontitis. 15. Patients with inadequate oral hygiene or unmotivated for adequate home care

Design outcomes

Primary

MeasureTime frameDescription
mid-facial recession (mm)6 months and 1 year after surgerymeasurement CEJ to free gingival margin with periodontal probe
PES (pink esthetic score)6 months and 1 year after surgeryassesses the soft tissue (gums); score 0-20
WES (white esthetic score6 months and 1 year after surgeryAssesses the tooth itself in relation to the neigboring natural elements; score 0-20

Secondary

MeasureTime frameDescription
buccal bone thicknessat implant surgery, 6 months and 1 year after surgerymeasured on CBCT; in mm
Surgical timeduring surgerymeasured from the moment of extraction to the placement of the provisional (seconds)
Implant success6 months and 1 year after surgeryIs the amount of marginal bone loss equal or less to the preestablished numbers to be called implant success? (yes/no)

Countries

Belgium

Contacts

PRINCIPAL_INVESTIGATORAndy Temmerman, Professor

UZLeuven, department of Oral Health Sciences, Periodontology

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 29, 2026